The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Serum Procalcitonin-Global Market Insights and Sales Trends 2024

Serum Procalcitonin-Global Market Insights and Sales Trends 2024

Publishing Date : Dec, 2023

License Type :
 

Report Code : 1872018

No of Pages : 114

Ask Your Query
Synopsis
The global Serum Procalcitonin market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Serum Procalcitonin in various end use industries. The expanding demands from the Medical Industry, Scientific Research and Veterinarian,, are propelling Serum Procalcitonin market. Procalcitonin Antigen, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Procalcitonin Antibody segment is estimated at % CAGR for the next seven-year period.
According to the Global Use of Medicines 2023 released by IQVIA Institute, the global drug expenditure in 2022 was about US$1.48 trillion (excluding COVID vaccine and treatment-related expenses), and it is predicted to grow at a rate of 3%-6% in the next few years. In terms of drug expenditure, this number in China was about 166 billion dollars in 2022. It is expected that the expenditure on medicines will increase in the next few years. From the perspective of demand, the trend of population aging, the increase of residents’ wealth and the improvement of health awareness will drive the demand for medicines.
Global Use of Medicines 2023 shows that the U.S. market spent about US$ 62.9 billion on medicines in 2022 on a net ex-factory basis. Overall growth slows as the Inflation Reduction Act (IRA) spends US$64 billion to reduce prescription drug prices, and the adoption of new treatments is expected to increase over the next few years. Besides, ex-factory discounts and rebates in drug distribution, the impact of patent expiration, and generic or biosimilar competition will also affect the U.S. pharmaceutical market.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Serum Procalcitonin, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Serum Procalcitonin market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Serum Procalcitonin market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Serum Procalcitonin sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Serum Procalcitonin covered in this report include Thermo Fisher, Roche Diagnostics, bioMerieux, HyTest, BBI Solutions, ProSpec, Wondfo, Ningbo Medicalsystem Biotechnology and Wuhan Easy Diagnosis Biomedicine, etc.
The global Serum Procalcitonin market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Thermo Fisher
Roche Diagnostics
bioMerieux
HyTest
BBI Solutions
ProSpec
Wondfo
Ningbo Medicalsystem Biotechnology
Wuhan Easy Diagnosis Biomedicine
Snibe
Vazyme Biotech
Getein Biotech
Hotgen Biotech
Lumigenex
Nanjing Norman Biological Technology
Kitgen
Beijing KeyGen
Beijing Apis
Global Serum Procalcitonin market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Serum Procalcitonin market, Segment by Type:
Procalcitonin Antigen
Procalcitonin Antibody
Global Serum Procalcitonin market, by Application
Medical Industry
Scientific Research
Veterinarian
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Serum Procalcitonin manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Serum Procalcitonin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index
1 Serum Procalcitonin Market Overview
1.1 Serum Procalcitonin Product Overview
1.2 Serum Procalcitonin Market Segment by Type
1.2.1 Procalcitonin Antigen
1.2.2 Procalcitonin Antibody
1.3 Global Serum Procalcitonin Market Size by Type
1.3.1 Global Serum Procalcitonin Market Size Overview by Type (2018-2029)
1.3.2 Global Serum Procalcitonin Historic Market Size Review by Type (2018-2023)
1.3.3 Global Serum Procalcitonin Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Serum Procalcitonin Sales Breakdown by Type (2018-2023)
1.4.2 Europe Serum Procalcitonin Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Serum Procalcitonin Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Serum Procalcitonin Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Serum Procalcitonin Sales Breakdown by Type (2018-2023)
2 Global Serum Procalcitonin Market Competition by Company
2.1 Global Top Players by Serum Procalcitonin Sales (2018-2023)
2.2 Global Top Players by Serum Procalcitonin Revenue (2018-2023)
2.3 Global Top Players by Serum Procalcitonin Price (2018-2023)
2.4 Global Top Manufacturers Serum Procalcitonin Manufacturing Base Distribution, Sales Area, Product Type
2.5 Serum Procalcitonin Market Competitive Situation and Trends
2.5.1 Serum Procalcitonin Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Serum Procalcitonin Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Serum Procalcitonin as of 2022)
2.7 Date of Key Manufacturers Enter into Serum Procalcitonin Market
2.8 Key Manufacturers Serum Procalcitonin Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Serum Procalcitonin Status and Outlook by Region
3.1 Global Serum Procalcitonin Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Serum Procalcitonin Historic Market Size by Region
3.2.1 Global Serum Procalcitonin Sales in Volume by Region (2018-2023)
3.2.2 Global Serum Procalcitonin Sales in Value by Region (2018-2023)
3.2.3 Global Serum Procalcitonin Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Serum Procalcitonin Forecasted Market Size by Region
3.3.1 Global Serum Procalcitonin Sales in Volume by Region (2024-2029)
3.3.2 Global Serum Procalcitonin Sales in Value by Region (2024-2029)
3.3.3 Global Serum Procalcitonin Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Serum Procalcitonin by Application
4.1 Serum Procalcitonin Market Segment by Application
4.1.1 Medical Industry
4.1.2 Scientific Research
4.1.3 Veterinarian
4.2 Global Serum Procalcitonin Market Size by Application
4.2.1 Global Serum Procalcitonin Market Size Overview by Application (2018-2029)
4.2.2 Global Serum Procalcitonin Historic Market Size Review by Application (2018-2023)
4.2.3 Global Serum Procalcitonin Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Serum Procalcitonin Sales Breakdown by Application (2018-2023)
4.3.2 Europe Serum Procalcitonin Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Serum Procalcitonin Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Serum Procalcitonin Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Serum Procalcitonin Sales Breakdown by Application (2018-2023)
5 North America Serum Procalcitonin by Country
5.1 North America Serum Procalcitonin Historic Market Size by Country
5.1.1 North America Serum Procalcitonin Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Serum Procalcitonin Sales in Volume by Country (2018-2023)
5.1.3 North America Serum Procalcitonin Sales in Value by Country (2018-2023)
5.2 North America Serum Procalcitonin Forecasted Market Size by Country
5.2.1 North America Serum Procalcitonin Sales in Volume by Country (2024-2029)
5.2.2 North America Serum Procalcitonin Sales in Value by Country (2024-2029)
6 Europe Serum Procalcitonin by Country
6.1 Europe Serum Procalcitonin Historic Market Size by Country
6.1.1 Europe Serum Procalcitonin Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Serum Procalcitonin Sales in Volume by Country (2018-2023)
6.1.3 Europe Serum Procalcitonin Sales in Value by Country (2018-2023)
6.2 Europe Serum Procalcitonin Forecasted Market Size by Country
6.2.1 Europe Serum Procalcitonin Sales in Volume by Country (2024-2029)
6.2.2 Europe Serum Procalcitonin Sales in Value by Country (2024-2029)
7 Asia-Pacific Serum Procalcitonin by Region
7.1 Asia-Pacific Serum Procalcitonin Historic Market Size by Region
7.1.1 Asia-Pacific Serum Procalcitonin Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Serum Procalcitonin Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Serum Procalcitonin Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Serum Procalcitonin Forecasted Market Size by Region
7.2.1 Asia-Pacific Serum Procalcitonin Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Serum Procalcitonin Sales in Value by Region (2024-2029)
8 Latin America Serum Procalcitonin by Country
8.1 Latin America Serum Procalcitonin Historic Market Size by Country
8.1.1 Latin America Serum Procalcitonin Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Serum Procalcitonin Sales in Volume by Country (2018-2023)
8.1.3 Latin America Serum Procalcitonin Sales in Value by Country (2018-2023)
8.2 Latin America Serum Procalcitonin Forecasted Market Size by Country
8.2.1 Latin America Serum Procalcitonin Sales in Volume by Country (2024-2029)
8.2.2 Latin America Serum Procalcitonin Sales in Value by Country (2024-2029)
9 Middle East and Africa Serum Procalcitonin by Country
9.1 Middle East and Africa Serum Procalcitonin Historic Market Size by Country
9.1.1 Middle East and Africa Serum Procalcitonin Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Serum Procalcitonin Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Serum Procalcitonin Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Serum Procalcitonin Forecasted Market Size by Country
9.2.1 Middle East and Africa Serum Procalcitonin Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Serum Procalcitonin Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Thermo Fisher
10.1.1 Thermo Fisher Company Information
10.1.2 Thermo Fisher Introduction and Business Overview
10.1.3 Thermo Fisher Serum Procalcitonin Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Thermo Fisher Serum Procalcitonin Products Offered
10.1.5 Thermo Fisher Recent Development
10.2 Roche Diagnostics
10.2.1 Roche Diagnostics Company Information
10.2.2 Roche Diagnostics Introduction and Business Overview
10.2.3 Roche Diagnostics Serum Procalcitonin Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Roche Diagnostics Serum Procalcitonin Products Offered
10.2.5 Roche Diagnostics Recent Development
10.3 bioMerieux
10.3.1 bioMerieux Company Information
10.3.2 bioMerieux Introduction and Business Overview
10.3.3 bioMerieux Serum Procalcitonin Sales, Revenue and Gross Margin (2018-2023)
10.3.4 bioMerieux Serum Procalcitonin Products Offered
10.3.5 bioMerieux Recent Development
10.4 HyTest
10.4.1 HyTest Company Information
10.4.2 HyTest Introduction and Business Overview
10.4.3 HyTest Serum Procalcitonin Sales, Revenue and Gross Margin (2018-2023)
10.4.4 HyTest Serum Procalcitonin Products Offered
10.4.5 HyTest Recent Development
10.5 BBI Solutions
10.5.1 BBI Solutions Company Information
10.5.2 BBI Solutions Introduction and Business Overview
10.5.3 BBI Solutions Serum Procalcitonin Sales, Revenue and Gross Margin (2018-2023)
10.5.4 BBI Solutions Serum Procalcitonin Products Offered
10.5.5 BBI Solutions Recent Development
10.6 ProSpec
10.6.1 ProSpec Company Information
10.6.2 ProSpec Introduction and Business Overview
10.6.3 ProSpec Serum Procalcitonin Sales, Revenue and Gross Margin (2018-2023)
10.6.4 ProSpec Serum Procalcitonin Products Offered
10.6.5 ProSpec Recent Development
10.7 Wondfo
10.7.1 Wondfo Company Information
10.7.2 Wondfo Introduction and Business Overview
10.7.3 Wondfo Serum Procalcitonin Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Wondfo Serum Procalcitonin Products Offered
10.7.5 Wondfo Recent Development
10.8 Ningbo Medicalsystem Biotechnology
10.8.1 Ningbo Medicalsystem Biotechnology Company Information
10.8.2 Ningbo Medicalsystem Biotechnology Introduction and Business Overview
10.8.3 Ningbo Medicalsystem Biotechnology Serum Procalcitonin Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Ningbo Medicalsystem Biotechnology Serum Procalcitonin Products Offered
10.8.5 Ningbo Medicalsystem Biotechnology Recent Development
10.9 Wuhan Easy Diagnosis Biomedicine
10.9.1 Wuhan Easy Diagnosis Biomedicine Company Information
10.9.2 Wuhan Easy Diagnosis Biomedicine Introduction and Business Overview
10.9.3 Wuhan Easy Diagnosis Biomedicine Serum Procalcitonin Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Wuhan Easy Diagnosis Biomedicine Serum Procalcitonin Products Offered
10.9.5 Wuhan Easy Diagnosis Biomedicine Recent Development
10.10 Snibe
10.10.1 Snibe Company Information
10.10.2 Snibe Introduction and Business Overview
10.10.3 Snibe Serum Procalcitonin Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Snibe Serum Procalcitonin Products Offered
10.10.5 Snibe Recent Development
10.11 Vazyme Biotech
10.11.1 Vazyme Biotech Company Information
10.11.2 Vazyme Biotech Introduction and Business Overview
10.11.3 Vazyme Biotech Serum Procalcitonin Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Vazyme Biotech Serum Procalcitonin Products Offered
10.11.5 Vazyme Biotech Recent Development
10.12 Getein Biotech
10.12.1 Getein Biotech Company Information
10.12.2 Getein Biotech Introduction and Business Overview
10.12.3 Getein Biotech Serum Procalcitonin Sales, Revenue and Gross Margin (2018-2023)
10.12.4 Getein Biotech Serum Procalcitonin Products Offered
10.12.5 Getein Biotech Recent Development
10.13 Hotgen Biotech
10.13.1 Hotgen Biotech Company Information
10.13.2 Hotgen Biotech Introduction and Business Overview
10.13.3 Hotgen Biotech Serum Procalcitonin Sales, Revenue and Gross Margin (2018-2023)
10.13.4 Hotgen Biotech Serum Procalcitonin Products Offered
10.13.5 Hotgen Biotech Recent Development
10.14 Lumigenex
10.14.1 Lumigenex Company Information
10.14.2 Lumigenex Introduction and Business Overview
10.14.3 Lumigenex Serum Procalcitonin Sales, Revenue and Gross Margin (2018-2023)
10.14.4 Lumigenex Serum Procalcitonin Products Offered
10.14.5 Lumigenex Recent Development
10.15 Nanjing Norman Biological Technology
10.15.1 Nanjing Norman Biological Technology Company Information
10.15.2 Nanjing Norman Biological Technology Introduction and Business Overview
10.15.3 Nanjing Norman Biological Technology Serum Procalcitonin Sales, Revenue and Gross Margin (2018-2023)
10.15.4 Nanjing Norman Biological Technology Serum Procalcitonin Products Offered
10.15.5 Nanjing Norman Biological Technology Recent Development
10.16 Kitgen
10.16.1 Kitgen Company Information
10.16.2 Kitgen Introduction and Business Overview
10.16.3 Kitgen Serum Procalcitonin Sales, Revenue and Gross Margin (2018-2023)
10.16.4 Kitgen Serum Procalcitonin Products Offered
10.16.5 Kitgen Recent Development
10.17 Beijing KeyGen
10.17.1 Beijing KeyGen Company Information
10.17.2 Beijing KeyGen Introduction and Business Overview
10.17.3 Beijing KeyGen Serum Procalcitonin Sales, Revenue and Gross Margin (2018-2023)
10.17.4 Beijing KeyGen Serum Procalcitonin Products Offered
10.17.5 Beijing KeyGen Recent Development
10.18 Beijing Apis
10.18.1 Beijing Apis Company Information
10.18.2 Beijing Apis Introduction and Business Overview
10.18.3 Beijing Apis Serum Procalcitonin Sales, Revenue and Gross Margin (2018-2023)
10.18.4 Beijing Apis Serum Procalcitonin Products Offered
10.18.5 Beijing Apis Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Serum Procalcitonin Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Serum Procalcitonin Industrial Chain Analysis
11.4 Serum Procalcitonin Market Dynamics
11.4.1 Serum Procalcitonin Industry Trends
11.4.2 Serum Procalcitonin Market Drivers
11.4.3 Serum Procalcitonin Market Challenges
11.4.4 Serum Procalcitonin Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Serum Procalcitonin Distributors
12.3 Serum Procalcitonin Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock